Uploaded January 2024 | Updated November 2026, 6 hours ago
La presentación, dada por la Dra. Silvia N. Tenembaum, el Dr. Carlos Pardo-Villamizar, el Dr. Jorge Andres Jimenez, la Dra. Maria Isabel Reyes-Mantilla y la Dra. Paula Barreras, proporcionó una visión detallada de los ensayos clínicos en NMOSD y MOGAD en pacientes pediátricos, así como discusiones sobre la importancia de la investigación, la vigilancia de la seguridad y los desafíos en la práctica clínica y la rehabilitación.
Trastornos Neuroinmunológicos Poco Frecuentes Simposio en Español 2023
Silvia N. Tenembaum, MD of Hospital Pediatría J.P. Garrahan, Argentina
Maria Isabel Reyes-Mantilla, MD of Hospital Simón Bolívar, Colombia
Paula Barreras, MD of Cedars-Sinai Medical Center, USA
La presentación, dada por la Dra. Silvia N. Tenembaum, el Dr. Carlos Pardo-Villamizar, el Dr. Jorge Andres Jimenez, la Dra. Maria Isabel Reyes-Mantilla y la Dra. Paula Barreras, proporcionó una visión detallada de los ensayos clínicos en NMOSD y MOGAD en pacientes pediátricos, así como discusiones sobre la importancia de la investigación, la vigilancia de la seguridad y los desafíos en la práctica clínica y la rehabilitación.
Trastornos Neuroinmunológicos Poco Frecuentes Simposio en Español 2023
Silvia N. Tenembaum, MD of Hospital Pediatría J.P. Garrahan, Argentina
Maria Isabel Reyes-Mantilla, MD of Hospital Simón Bolívar, Colombia
Paula Barreras, MD of Cedars-Sinai Medical Center, USA

![2026 RNDS | New Diagnostic Criteria Update: Transverse Myelitis
In this session from the 2026 Rare Neuroimmune Disorders Symposium (RNDS), Kyle Blackburn, MD, of the University of Texas Southwestern, spoke about the proposed update to the 2002 diagnostic criteria for transverse myelitis (TM) [00:02:00]. Dr. Blackburn explained why the criteria need revising, including acute flaccid myelitis (AFM) and the discovery of aquaporin-4 and MOG antibodies [00:04:06]. He described the proposal to say myelitis and name the cause, such as MOG antibody disease (MOGAD), with idiopathic used when no cause is found [00:12:48]. He walked through the proposed steps: confirming a spinal cord problem, MRI and spinal fluid testing, the timing of symptoms, and a list of conditions that can look like myelitis [00:16:04]. He shared the journal comments the group received, then answered questions about people diagnosed with TM years ago, repeat testing, 7T MRI, and finding care [00:28:14].
Kyle Blackburn, MD, is an assistant professor in the Department of Neurology at UT Southwestern Medical Center in Dallas, Texas. He earned his medical degree at the University of Kentucky College of Medicine, completed his neurology residency at UT Southwestern, and stayed to complete a fellowship in neuroimmunology, where he trained with Dr. Greenberg and earned the James T. Lubin Clinician Scientist Award from the Siegel Rare Neuroimmune Association (SRNA). During his fellowship he launched the Comprehensive Outcome Registry Exploring Transverse Myelitis (CORE TM) study, and he joined the UT Southwestern faculty in 2020.
Benjamin Greenberg, MD, MHS, is Vice Chair of Translational Research and Strategic Initiatives and Director of the Transverse Myelitis and Neuromyelitis Optica Program at UT Southwestern Medical Center and Childrens Medical Center Dallas. He is recognized internationally as an expert in rare autoimmune disorders of the central nervous system, including transverse myelitis, neuromyelitis optica spectrum disorder, and acute disseminated encephalomyelitis, and he sees both adults and children in his clinical practice.
00:00 Welcome and Speaker Introduction
02:00 Why Update the 2002 Criteria
07:50 What Has Changed Since 2002
11:04 What New Criteria Need to Include
12:48 From Transverse Myelitis to Myelitis
16:04 Confirming a Spinal Cord Problem
20:44 Evidence of Inflammation
23:20 Diagnosing Myelitis in 2026
28:14 Where the Criteria Stand Now
30:34 Questions from the Audience
42:42 Closing Thoughts 2026 RNDS | New Diagnostic Criteria Update: Transverse Myelitis](https://i.ytimg.com/vi/nI5hUAB_uug/mqdefault.jpg)
![2026 RNDS | Community Solutions Lab: “What Works for Me” + Funding Pathways
In this session from the 2026 Rare Neuroimmune Disorders Symposium (RNDS), Sandy Hanebrink of Touch the Future, Inc. and Leah Campbell, SRNAs Community Support Coordinator, led an interactive Community Solutions Lab, opening with how Sandy built a network of resources after becoming paralyzed and how to filter good information from bad [00:03:48]. They answered questions submitted by attendees about insurance denials and appeals, including documenting every call and contacting pharmaceutical patient access programs [00:06:46], and about raising awareness of accessibility through local meetings, disability organizations, and the media [00:10:37]. Sandy described lifts, seat elevation, tilt and recline, and glide sheets for transfers [00:16:18]. The two of them also shared ways to reduce burnout for people living with these disorders and their care partners, including respite programs and open communication [00:18:56].
Sandy Hanebrink, OTR/L, CLP, FAOTA, is the executive director of Touch the Future, Inc. She lives with transverse myelitis (TM) and is a Paralympian with gold, silver and bronze medals, who still holds American records in shot put, discus, javelin and swimming. Sandy is an occupational therapist whose work focuses on advocacy and assistive technology, connecting people with disabilities and service providers to the resources and funding they need to reach their life goals. She has presented and published widely on educating and employing people with disabilities, reasonable accommodations, disability laws, disabled sports and assistive technology, and has received many awards for her work.
00:00 Welcome and Introductions
03:48 Building a Network of Resources
06:46 Insurance Denials and Appeals
10:37 Raising Awareness of Accessibility
16:18 Lifts and Transfer Equipment
18:56 Reducing Burnout for Care Partners
22:58 Closing and Staying Connected 2026 RNDS | Community Solutions Lab: “What Works for Me” + Funding Pathways](https://i.ytimg.com/vi/oJ2RAGsbxss/mqdefault.jpg)


![2024 RNDS | Synaptic Dysfunction in Rare Neuroimmune Disorders
At the 2024 RNDS, Dr. Haiwen Chen shared her journey as a James T. Lubin Fellow and her transition into pediatric neuroimmunology [00:00:30]. She highlighted the prevalence of MOGAD in pediatric demyelinating syndromes and the significance of examining both white and gray matter in such diseases [00:04:12]. Through detailed in vitro studies, she demonstrated how oligodendrocytes influence neuronal activity and synaptic signaling, shedding light on rare neuroimmune diseases effects [00:07:00]. She emphasized the need for better biomarkers and continued research to improve treatment and understanding of these diseases [00:14:57]. Finally, Dr. Chen answered questions from the audience [00:16:48]. Please note that the information shared during this session is for informational purposes only and is not medical advice.
You can view the presentation slides here:
https://files.wearesrna.org/symposia/2024_rnds/slides/2024RNDS_Chen.pdf
00:00 Introduction and Personal Journey
01:19 Understanding Pediatric Neuroimmune Diseases
02:10 MRI Insights and Cognitive Impairment
04:07 Neuronal Circuits and Synapses
05:34 Role of Glial Cells in Neuronal Function
07:00 In Vitro Models and Experimental Findings
09:38 Neuronal Signalling and Synaptic Function
14:57 Future Research Directions
16:00 Conclusion and Acknowledgements
16:48 Q&A Session 2024 RNDS | Synaptic Dysfunction in Rare Neuroimmune Disorders](https://i.ytimg.com/vi/pOeIH4DCPUA/mqdefault.jpg)

![205. Dr. Alexandra Kornbluh
The Community Meets Clinic podcast series introduces clinicians and healthcare personnel specializing in rare neuroimmune disorders. In this episode, Krissy Dilger of SRNA interviewed Dr. Alexandra Kornbluh from Childrens National Hospital in Washington, D.C. about her role and journey into neurology and neuroimmunology.
Dr. Kornbluh discussed her interest in the fast-paced nature of neuroimmunology and her involvement in clinical research, particularly in MOG antibody disease (MOGAD) [00:01:32]. She elaborated on the multidisciplinary approach at Childrens National Hospital that supports comprehensive care and ongoing research for pediatric neuroimmune disorders [00:04:58]. Dr. Kornbluh emphasized her commitment to holistic care and the future advancements in treatment and diagnostics for rare neuroimmune conditions [00:05:44].
Alexandra Kornbluh, MD is Associate Program Director for the Child Neurology residency and Co-Program Director of the Pediatric Neuroimmunology Fellowship at Children’s National Hospital in Washington, D.C. She completed her medical training at the Johns Hopkins School of Medicine and her pediatric and child neurology residency training through Nationwide Children’s Hospital in Columbus, Ohio. She then pursued additional subspecialty fellowship training in pediatric multiple sclerosis and related demyelinating diseases. Through this fellowship, she gained expertise in caring for both children and adults across the age-span of neuroinflammatory diseases at the Children’s Hospital of Philadelphia and the University of Pennsylvania.
Dr. Kornbluh sees patients from the greater Washington, D.C., area as well as second opinion consultations for pediatric demyelinating disease and related disorders within the multidisciplinary neuroimmunology program. She also evaluates patients with headaches and provides general neurology care for patients.
Dr. Kornbluh serves as the Director of Investigational Therapeutics through the pediatric neuroimmunology program and is the principal investigator for clinical research studies in pediatric demyelinating conditions. Her research interests include pediatric multiple sclerosis (MS), myelin oligodendrocyte glycoprotein antibody-associated disorders (MOGAD), and other related demyelinating conditions. You can view her medical profile here:
https://appointments.childrensnational.org/provider/alexandra-behar-kornbluh/2359826
01:32 Dr. Kornbluhs Journey into Neuroimmunology
03:29 Focus on Rare Neuroimmune Disorders
04:58 Childrens National Neuroimmunology Clinic
05:44 Multidisciplinary Care Approach
07:31 Personal Insights and Self-Care
08:25 Message to Families and Final Thoughts
09:48 Hope for the Future 205. Dr. Alexandra Kornbluh](https://i.ytimg.com/vi/qaYjK7b0caE/mqdefault.jpg)


![1307. Parenting is Hard | Part 3
At the end of this mini-series, we will host a Q&A episode where Barbara will answer questions from the community. To submit your question, please visit https://srna.ngo/submit
In the third part of the “Ask the Expert, Research Edition” mini-series, “Parenting is Hard,” Krissy Dilger of SRNA was joined by Barbara Babcock to further explore her research concerning the changing beliefs around parenting when a child has been diagnosed with a rare neuroimmune disorder. Barbara discussed how beliefs around being fair as a parent could change and the various sub-themes supporting this idea, including redefinition of fairness and the challenge of balancing attention among children [00:03:30]. She highlighted the impact of societal and historical contexts on parenting norms and the struggles parents face in managing new caregiving responsibilities and learning new skills [00:12:45]. The importance of redefining what it means to be a good parent in the context of a child with additional needs was emphasized throughout the episode [00:24:00].
Barbara Babcock works as a Family Therapist in a child and adolescent mental health outpatient unit in the United Kingdoms National Health Service. In her private practice, she works with individuals and couples who are navigating challenging health issues and wish to get their lives back. She obtained her Master of Science in Family Therapy from the Institute of Psychiatry, Psychology, and Neuroscience at Kings College London. Barbara also has a Master of Arts in Coaching Psychology/Psychological Coaching and her dissertation research focused on the impact that a systemic approach to coaching has on the wellbeing of adults who have a rare neuroimmune disorder and their primary caregivers. Previously, she was Chair of the Transverse Myelitis Society, from 2013 to 2016, and led their Family Weekend from 2015 to 2019, an event to support families who have a child/adolescent with a rare neuroimmune disorder to discover their potential through challenging outdoor activities. She had transverse myelitis in 2008 and is originally from Pennsylvania, USA. You can contact her at barbara@returntowellness.co.uk and her website is www.returntowellness.co.uk
00:00 Introduction
00:27 Meet the Expert: Barbara Babcock
01:38 Exploring Parental Beliefs and Fairness
03:37 Balancing Attention Among Children
07:49 Cultural and Societal Influences on Parenting
11:08 Challenges in Managing Illness and Fairness
19:37 Learning New Skills and Roles
25:52 Redefining Good Parenting
27:43 Conclusion 1307. Parenting is Hard | Part 3](https://i.ytimg.com/vi/rxP73iY4HjA/mqdefault.jpg)